-
2022-502082-22-00
11
2023-09-14
prediabetes
-
2022-501831-18-00
4
2023-09-13
Patients with hematologic malignancies and undergoing allogenic hemato
-
2022-502732-39-00
10
2023-09-01
Previously treated non-ocular advanced melanoma
-
2024-516647-79-00
11
2023-06-28
Persistent Spinal Pain Syndrome Type II (PSPS T2)
-
2023-509046-36-00
5
2023-04-26
Active Ulcerative Colitis (UC) or Crohn's disease (CD)
-
2023-503481-23-00
5
2023-03-20
Maintenance treatment in metastatic non-squamous lung cancer
-
2024-514138-19-00
4
2023-02-15
Patients with non-small cell lung cancer
-
2022-501181-22-01
4
2023-02-06
Pancreatic adenocarcinoma
-
2024-513998-48-00
6
2023-02-02
Volutary women who wish to donate their oocytes
-
2022-502140-13-00
6
2023-01-11
Atrial fibrillation
Acute coronary syndrome
Chronic coronary syndrome
-
2023-506239-14-00
5
2022-12-13
Crohn’s Disease
-
2024-514139-50-00
5
2022-11-14
Multiple myeloma
-
2024-510990-21-00
10
2022-11-11
Mucopolysaccharidosis Type II [MPS II]
-
2023-508389-13-00
5
2022-11-08
Combined endpoint of all-cause mortality, kidney failure, and hospital
-
2024-514087-11-02
4
2022-10-03
Melanoma
-
2022-500311-39-00
6
2022-09-08
Patients with Crohn's disease undergoing surgery and having at least o
-
2024-513938-38-00
7
2022-04-06
Chronic HIV infection
-
2023-509045-13-00
5
2022-02-28
Moderately to severely active Crohn's disease (CD)
-
2023-503404-89-00
3
2021-12-08
Relapsed or Refractory Multiple Myeloma R/R MM
-
2024-512671-12-00
10
2021-03-05
Unresectable head and neck squamous cell carcinoma, metastatic head an
-
2024-515625-29-00
5
2020-06-16
Apnea of prematurity
-
2024-514642-37-00
6
2020-01-31
Perioperative anxiety in children scheduled for an elective circumcisi
-
2024-518568-11-00
4
2019-02-04
Hematological malignancies confirmed histologically:
- AML in morphol
-
2023-504201-36-00
10
2018-12-21
Defined by parent protocol. The study will enroll all adult and paedia